Rosenblatt maintains Dolby Laboratories at Buy, lowers price target to $75 from $80
Rosenblatt kept Dolby Laboratories at Buy but reduced its price target to $75 from $80, a 6.2% cut. The new target suggests a 27.5% upside from the Nov 17 close of $58.82, according to the firm.
How this was made

The 30-second read
Why it matters
This is primarily a valuation update rather than a fundamental change, so it is more likely to affect positioning and sentiment than to drive a major repricing by itself.
Market read
Traders may adjust expectations for DLB’s valuation upside, but the unchanged Buy rating limits downside conviction.
What to watch
The article provides no thesis details for the target reduction, so traders may discount the signal strength versus other analysts’ concurrent views.
Background
The piece reports an analyst action from Rosenblatt: rating maintained, price target lowered.
Ticker impact
Rosenblatt maintained Dolby Laboratories at Buy and cut its price target to $75 from $80, implying a lower valuation upside versus the prior target.
Likely mild downside bias as traders price in the lower target, partially offset by the unchanged Buy rating.
The article is a single-analyst note with no new company fundamentals, but the explicit target reduction is a direct, tradable input for valuation expectations.
Market effects
Limited read-through to the broader audio/entertainment tech space because it is a single-name target change without new sector data.
No clear regional spillover indicated; this is company-specific analyst commentary.
Minimal global relevance, as the update does not cite international regulatory, supply, or demand changes.
Counterpoint
Because the rating stays at Buy, the market may treat the target cut as routine and focus on other catalysts (earnings, guidance, product news) rather than the PT delta.
Key entities
- companyDolby Laboratories
Subject of the analyst note, with Buy rating maintained and price target reduced to $75 from $80.
- analyst_firmRosenblatt
Issued the maintained Buy rating and lowered price target.


